financetom
Business
financetom
/
Business
/
Chubb Insider Sold Shares Worth $403,365, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chubb Insider Sold Shares Worth $403,365, According to a Recent SEC Filing
May 17, 2024 10:07 AM

12:32 PM EDT, 05/17/2024 (MT Newswires) -- Annmarie T Hagan, Chief Accounting Officer, on May 16, 2024, sold 1,529 shares in Chubb ( CB ) for $403,365. Following the Form 4 filing with the SEC, Hagan has control over a total of 7,718 shares of the company, with 7,718 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/896159/000121390024044597/xslF345X03/marketforms-65953.xml

Price: 272.88, Change: +8.00, Percent Change: +3.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Crown Castle Insider Sold Shares Worth $1,128,839, According to a Recent SEC Filing
Crown Castle Insider Sold Shares Worth $1,128,839, According to a Recent SEC Filing
Jul 25, 2024
03:18 AM EDT, 07/25/2024 (MT Newswires) -- Michael Joseph Kavanagh, Executive Vice President and Chief Commercial Officer of Towers, on July 23, 2024, sold 10,883 shares in Crown Castle ( CCI ) for $1,128,839. Following the Form 4 filing with the SEC, Kavanagh has control over a total of 76,730 shares of the company, with 75,127 shares held directly and...
Halozyme Therapeutics Insider Sold Shares Worth $1,100,023, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $1,100,023, According to a Recent SEC Filing
Jul 25, 2024
03:19 AM EDT, 07/25/2024 (MT Newswires) -- Michael J. LaBarre, Chief Technical Officer & Senior Vice President, on July 23, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $1,100,023. Following the Form 4 filing with the SEC, LaBarre has control over a total of 168,176 shares of the company, with 168,176 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000141588924020055/xslF345X03/form4-07242024_090711.xml...
Vaxcyte Insider Sold Shares Worth $1,263,912, According to a Recent SEC Filing
Vaxcyte Insider Sold Shares Worth $1,263,912, According to a Recent SEC Filing
Jul 25, 2024
03:20 AM EDT, 07/25/2024 (MT Newswires) -- Grant Pickering, Director, Chief Executive Officer, on July 23, 2024, sold 15,000 shares in Vaxcyte ( PCVX ) for $1,263,912. Following the Form 4 filing with the SEC, Pickering has control over a total of 765,764 shares of the company, with 478,888 shares held directly and 286,876 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909424000039/xslF345X03/wk-form4_1721857439.xml Price:...
BAT profit beats forecasts but target for smoking alternatives in doubt
BAT profit beats forecasts but target for smoking alternatives in doubt
Jul 25, 2024
LONDON, July 25 (Reuters) - British American Tobacco ( BTI ) reported a 1.3% rise in half-year profit on Thursday, exceeding analyst expectations, but said it was likely to fall short of its 2025 ambitions on smoking alternatives. While BAT is looking to grow its revenue from smoking alternatives, it still makes most of its money from tobacco. But in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved